Bambino Gesù Hospital And Research Institute
Clinical trials sponsored by Bambino Gesù Hospital And Research Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Engineered immune cells take on childhood leukemia and lymphoma Results expected Mar 2027 (estimated)
-
Engineered immune cells take on tough childhood cancers
Disease control Recruiting nowThis study is testing a new treatment called CD7-CART01 for children whose T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma has come back or not responded to standard therapy. The treatment uses the child's own immune cells, which are modified in a lab to recognize a…
Phase 1/2 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Fresh donor cells take on childhood leukemia in early trial
Disease control Recruiting nowThis early-stage trial is testing a one-time infusion of specially engineered immune cells from a healthy donor in 24 children and young adults with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. The main goal is to check safety and find the…
Phase 1 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC